Pegasys 135mcg Injection
By Pegasys
Rx
1ml Injection in a Vial

Composition
Pegylated Interferon Alpha 2A(135mcg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
October, 2025

liver
Pegasys 135mcg Injection is considered to be safe for individuals with liver disease based on the available data. It is likely that adjusting the dosage of Pegasys 135mcg Injection may not be necessary for these patients. However, it is crucial to consult your doctor before using this medication. Regular monitoring of liver function tests is recommended while taking Pegasys 135mcg Injection to ensure the safety and effectiveness of the treatment.

kidney
Pegasys 135mcg Injection requires caution in patients with kidney disease. Adjusting the dose may be necessary. Always consult your doctor before using this medication.

alcohol
When using Pegasys 135mcg Injection, it is important to be cautious when consuming alcohol. Consult your doctor for guidance on the combination.

driving
Patients using Pegasys 135mcg Injection may experience dizziness, confusion, somnolence, and fatigue. It is advised to avoid driving due to these potential side effects.

pregnancy
Pegasys 135mcg Injection is considered unsafe during pregnancy. Limited human studies indicate potential risks to the developing baby based on animal studies. Your doctor will assess the benefits and risks for you. Please consult your doctor.

breastfeeding
During breastfeeding, Pegasys 135mcg Injection is considered safe based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Interferons |
Therapeutic Class | - |
Action Class | Interferons |
₹13884
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025